Le Lézard
Classified in: Health, Sports and recreation
Subject: SVY

Global Diabetic Footwear Market 2017-2021: Segmentation By Distribution Channel



DUBLIN, October 4, 2017 /PRNewswire/ --

The "Global Diabetic Footwear Market 2017-2021" report has been added to Research and Markets' offering.

Research and Markets Logo

The report forecasts the global diabetic footwear market to grow at a CAGR of 7.82% during the period 2017-2021.

The report, Global Diabetic Footwear Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

The latest trend gaining momentum in the market is the availability of products online. Diabetic footwear is comparatively a difficult category to shop for online due to the nature of their use and the absence of prior product knowledge. However, with retailers concentrating on enhancing the online shopping experience through targeted marketing and effective online education, there has been improvement in online sales. This has increased the comfort level of consumers to buy products online for this category. Many sites now have live chat options to instantly address queries, which was not possible earlier with online purchases. Vendors are interacting with consumers frequently to provide consumers health education.

According to the report, one of the major drivers for this market is the rise in income level of consumers. The per capita disposable income exhibits low volatility in developed countries because of a spike in double-income households. This increases the purchasing power of such households. The disposable income is increasing globally, especially at a fast rate in developing countries such as India, China, Brazil, Malaysia, Indonesia, and Vietnam. This results in significant opportunities for companies present in developing countries; companies in developed countries also have the opportunity to expand their businesses in these regions, thereby affecting their market growth.

Further, the report states that one of the major factors hindering the growth of this market is the low penetration in developing countries. Due to the lack of advanced healthcare facilities and well-structured stores, patients in many developing countries, especially in rural areas, are not able to avail healthcare products such as diabetic footwear, thus impacting the market negatively. The limited number of multispecialty and superspecialty hospitals and lack of skilled physicians, nurses, and other service providers affect healthcare service, including diabetic treatment. Further, the limited number of medical studies and healthcare practices restricts the growth in the number of skilled medical professionals. Thus, marginal patientcare results in the slow growth of the market.

Key vendors

Other prominent vendors

Key Topics Covered:

Part 01: Executive Summary

Part 02: Scope Of The Report

Part 03: Research Methodology

Part 04: Introduction

Part 05: Market Landscape

Part 06: Market Segmentation By Distribution Channel

Part 07: Geographical Segmentation

Part 08: Decision Framework

Part 09: Drivers And Challenges

Part 10: Market Trends

Part 11: Vendor Landscape

Part 12: Key Vendor Analysis

Part 13: Appendix

For more information about this report visit https://www.researchandmarkets.com/research/rpw4tj/global_diabetic

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716


These press releases may also interest you

at 18:34
Blessed Herbs Cafe and Mount Zion Rastafarian Church founder and practicing Rasta George Metropoulos today announced the launch of the organization's first holiday season food and cash drive. Directly benefiting the neighborhood's less fortunate...

at 11:40
A new article published today in The New England Journal of Medicine shows that 42 percent of diffuse large B cell lymphoma patients treated with axicabtagene ciloleucel, offered commercially under the brand name Yescartatm, remain in remission 15...

at 10:47
Novartis today announced updated results from the JULIET clinical trial demonstrating sustained responses with Kymriahtm (tisagenlecleucel) suspension for intravenous infusion, formerly CTL019, in adult patients with relapsed or refractory (r/r)...

at 10:30
For people with certain types of aggressive, refractory blood cancers, treatment options are woefully limited. But three studies being presented today at the 59th American Society of Hematology (ASH) Annual Meeting and Exposition in Atlanta spotlight...

at 08:48
Four studies being presented today at the 59th American Society of Hematology (ASH) Annual Meeting and Exposition in Atlanta highlight the multiple ways in which novel targeted cancer therapies are now being deployed to improve outcomes and quality...

at 08:32
The number of variants identified as being associated with cancer risk and progression is rapidly growing. Meanwhile, advances in medical genomics are paving the way to novel approaches for the diagnosis, management, and treatment of patients with...




News published on 4 october 2017 at 09:15 and distributed by: